Srivastava S K, Ansari N H, Hawkins L A, Wiktorowicz J E
Biochem J. 1979 Jun 1;179(3):657-64. doi: 10.1042/bj1790657.
Antibodies against placental hexosaminidase A and kidney alpha-subunits were raised in rabbits after cross-linking the antigens with glutaraldehyde. Anti-(alpha(n)-subunit) antiserum (anti-alpha(n)) precipitated hexosaminidase A but not hexosaminidase B, whereas anti-(hexosaminidase A) antiserum precipitated both hexosaminidases A and B. Specific anti-(hexosaminidase A) antiserum was prepared by absorbing antiserum with hexosaminidase B. Both anti-alpha(n) and anti-(hexosaminidase A) antisera precipitated the CR (cross-reacting) material from eight unrelated patients with Tay-Sachs disease. Immunotitration, immunoelectrophoresis, double-immunodiffusion and radial-immunodiffusion techniques were used to demonstrate the presence of CR material. The CR-material-antibody complex was enzymically inactive. Antiserum raised against kidney or placental hexosaminidase A, without cross-linking with glutaraldehyde, failed to precipitate the CR material, implying that treatment of the protein with glutaraldehyde exposes antigenic determinants that are hidden in the native protein. Since anti-(hexosaminidase B) antiserum did not precipitate the CR material during the immunoelectrophoresis of Tay-Sachs liver extracts, it is suggested that altered alpha-subunits do not combine with beta-subunits. By using immunotitration we have demonstrated the competition between the hexosaminidase B-free Tay-Sachs liver extract and hexosaminidase A for the common binding sites on monospecific anti-(cross-linked hexosaminidase A) antiserum. The amount of CR material in the liver samples from seven cases of Tay-Sachs desease was found to be in the same range as theoretically calculated alpha-subunits in normal liver samples. Similar results were obtained by the radial-immunodiffusion studies. The present studies therefore suggest that Tay-Sachs disease is caused by a structural-gene mutation.
将胎盘氨基己糖苷酶A和肾脏α亚基与戊二醛交联后,在兔体内产生了针对它们的抗体。抗(α(n)亚基)抗血清(抗α(n))沉淀了氨基己糖苷酶A,但未沉淀氨基己糖苷酶B,而抗(氨基己糖苷酶A)抗血清沉淀了氨基己糖苷酶A和B。通过用氨基己糖苷酶B吸收抗血清制备了特异性抗(氨基己糖苷酶A)抗血清。抗α(n)和抗(氨基己糖苷酶A)抗血清均沉淀了8例无关的泰-萨克斯病患者的交叉反应(CR)物质。采用免疫滴定、免疫电泳、双向免疫扩散和放射免疫扩散技术来证明CR物质的存在。CR物质-抗体复合物无酶活性。未经戊二醛交联而产生的针对肾脏或胎盘氨基己糖苷酶A的抗血清未能沉淀CR物质,这意味着用戊二醛处理蛋白质会暴露出天然蛋白质中隐藏的抗原决定簇。由于在泰-萨克斯病肝脏提取物的免疫电泳过程中,抗(氨基己糖苷酶B)抗血清未沉淀CR物质,因此提示改变的α亚基不与β亚基结合。通过免疫滴定,我们证明了不含氨基己糖苷酶B的泰-萨克斯病肝脏提取物与氨基己糖苷酶A之间对单特异性抗(交联氨基己糖苷酶A)抗血清上共同结合位点的竞争。发现7例泰-萨克斯病患者肝脏样本中的CR物质含量与正常肝脏样本中理论计算的α亚基含量在同一范围内。放射免疫扩散研究也得到了类似结果。因此,本研究提示泰-萨克斯病是由结构基因突变引起的。